Blog

Ideas for pharma marketing teams
building with AI.

Notes on grounded content, MLR-native workflows, and what actually changes once AI is writing the first draft.

/

Try

Compliance10 min read

How to run doctor consent-based video campaigns that actually convert

Consent is not just a legal checkbox. For pharma teams, it is the difference between cold distribution and a trusted HCP content channel that compounds over time.

SwishX Team · Jul 31, 2026Read article

Latest

View all

Compliance9 min readThe creator wrote the caption. FDA will still read it as your promotionPay a creator, brief them or approve their post, and FDA treats what they publish as your company's promotion. What FDA and the FTC expect from influencer content, why the 2025 enforcement push raised the stakes, and a checklist for running a program that holds up.Nov 2, 2026
AI Strategy9 min readAn AI avatar can explain your drug, as long as nobody mistakes it for a doctorAI video can turn approved claims into explainers, HCP education and localized clips in days. The rules that apply to synthetic presenters, real faces and voices, and on-screen ISI, and how to take an AI video through MLR.Oct 30, 2026
AI Strategy8 min readHigh call volume says your rep was busy, not that the call was any goodCall volume is the easiest pharma sales KPI to count and the least able to tell you whether a rep is effective. The metrics worth tracking beyond activity, why prescriptions are hard to pin on one rep, and a balanced scorecard that does not reward cutting corners.Oct 30, 2026
Compliance9 min readFDA's DTC crackdown and the end of adequate provision: what pharma marketers should do nowFDA sent a wave of enforcement letters over DTC advertising in September 2025 and has put a rule to remove adequate provision on its agenda. What has changed, what has not, and how to prepare broadcast, digital and social content in 2026.Oct 29, 2026

Explore by topic

Start with the questions your team is asking.

All articles

Everything we have published, newest first.

Compliance9 min read

The creator wrote the caption. FDA will still read it as your promotion

Pay a creator, brief them or approve their post, and FDA treats what they publish as your company's promotion. What FDA and the FTC expect from influencer content, why the 2025 enforcement push raised the stakes, and a checklist for running a program that holds up.

Nov 2, 2026

AI Strategy9 min read

An AI avatar can explain your drug, as long as nobody mistakes it for a doctor

AI video can turn approved claims into explainers, HCP education and localized clips in days. The rules that apply to synthetic presenters, real faces and voices, and on-screen ISI, and how to take an AI video through MLR.

Oct 30, 2026

AI Strategy8 min read

High call volume says your rep was busy, not that the call was any good

Call volume is the easiest pharma sales KPI to count and the least able to tell you whether a rep is effective. The metrics worth tracking beyond activity, why prescriptions are hard to pin on one rep, and a balanced scorecard that does not reward cutting corners.

Oct 30, 2026

Compliance9 min read

FDA's DTC crackdown and the end of adequate provision: what pharma marketers should do now

FDA sent a wave of enforcement letters over DTC advertising in September 2025 and has put a rule to remove adequate provision on its agenda. What has changed, what has not, and how to prepare broadcast, digital and social content in 2026.

Oct 29, 2026

Magic Studio

Want to see Magic Studio on your brand?

Video, docs, ads, approved email and web, made from your approved claims and ready for MLR review.

Book a demo

Platform9 min read

Your launch content is built on a label that doesn't exist yet

Most launch content is written months before the label it depends on is final, and the hardest week of a launch is the one where the two meet. A working-back checklist for brand and content teams, from the PDUFA date to the first 120 days.

Oct 28, 2026

AI Strategy8 min read

Your managers ride along every week. Most of it isn't coaching

First-line managers spend most of their coaching time on ride-alongs that end in a report, not a better rep. What good pharma sales coaching looks like, how to coach compliance and calibrate managers, and a weekly rhythm that fits a real district.

Oct 27, 2026

Compliance8 min read

The label changed this morning. Your live assets still say the old thing

A new warning, boxed warning or indication change turns every live piece built on the old prescribing information into a liability. How to find each affected asset, decide what to pull and what to revise, and get revised pieces back into the field and onto Form FDA 2253.

Oct 26, 2026

AI Strategy8 min read

Omnichannel isn't more channels. It's one conversation the physician can follow

Most pharma brands reach physicians through many channels that never talk to each other, and call it omnichannel. What it takes to orchestrate rep calls, email, web, media and medical touchpoints around the HCP, and a plan to start.

Oct 23, 2026